BNP Paribas Financial Markets’s Inspire Medical Systems INSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $16.5M | Sell |
319,758
-135,052
| -30% | -$9.45M | 0.01% | 1287 |
|
|
2025
Q4 | $41.9M | Sell |
454,810
-67,370
| -13% | -$6.45M | 0.02% | 772 |
|
|
2025
Q3 | $38.7M | Buy |
522,180
+462,412
| +774% | +$46.8M | 0.02% | 745 |
|
|
2025
Q2 | $7.76M | Buy |
59,768
+118
| +0.2% | +$17.1K | ﹤0.01% | 1598 |
|
|
2025
Q1 | $9.5M | Buy |
59,650
+51,659
| +646% | +$9.35M | 0.01% | 1430 |
|
|
2024
Q4 | $1.48M | Buy |
7,991
+3,280
| +70% | +$637K | ﹤0.01% | 2562 |
|
|
2024
Q3 | $994K | Buy |
4,711
+2,352
| +100% | +$409K | ﹤0.01% | 2502 |
|
|
2024
Q2 | $316K | Buy |
2,359
+62
| +3% | +$11.7K | ﹤0.01% | 2892 |
|
|
2024
Q1 | $493K | Buy |
2,297
+1,084
| +89% | +$212K | ﹤0.01% | 2848 |
|
|
2023
Q4 | $247K | Sell |
1,213
-76,757
| -98% | -$12.4M | ﹤0.01% | 3126 |
|
|
2023
Q3 | $15.5M | Buy |
77,970
+7,522
| +11% | +$1.9M | 0.02% | 715 |
|
|
2023
Q2 | $22.9M | Buy |
70,448
+32,084
| +84% | +$9.17M | 0.03% | 557 |
|
|
2023
Q1 | $8.98M | Buy |
38,364
+33,782
| +737% | +$8.54M | 0.01% | 953 |
|
|
2022
Q4 | $1.15M | Sell |
4,582
-9,895
| -68% | -$2.11M | ﹤0.01% | 2081 |
|
|
2022
Q3 | $2.57M | Buy |
14,477
+8,210
| +131% | +$1.65M | ﹤0.01% | 1780 |
|
|
2022
Q2 | $1.14M | Buy |
6,267
+3,261
| +108% | +$650K | ﹤0.01% | 2116 |
|
|
2022
Q1 | $772K | Sell |
3,006
-2,876
| -49% | -$657K | ﹤0.01% | 2484 |
|
|
2021
Q4 | $1.35M | Buy |
5,882
+493
| +9% | +$120K | ﹤0.01% | 2372 |
|
|
2021
Q3 | $1.25M | Buy |
5,389
+3,521
| +188% | +$735K | ﹤0.01% | 2225 |
|
|
2021
Q2 | $361K | Sell |
1,868
-2,294
| -55% | -$455K | ﹤0.01% | 2681 |
|
|
2021
Q1 | $861K | Sell |
4,162
-768
| -16% | -$163K | ﹤0.01% | 2232 |
|
|
2020
Q4 | $927K | Sell |
4,930
-1,213
| -20% | -$198K | ﹤0.01% | 2066 |
|
|
2020
Q3 | $793K | Sell |
6,143
-415
| -6% | -$45.7K | ﹤0.01% | 1935 |
|
|
2020
Q2 | $571K | Sell |
6,558
-20,212
| -76% | -$1.55M | ﹤0.01% | 2047 |
|
|
2020
Q1 | $1.61M | Buy |
26,770
+24,726
| +1,210% | +$1.83M | ﹤0.01% | 1609 |
|
|
2019
Q4 | $152K | Sell |
2,044
-238
| -10% | -$15.3K | ﹤0.01% | 3092 |
|
|
2019
Q3 | $139K | Buy |
2,282
+532
| +30% | +$35K | ﹤0.01% | 2939 |
|
|
2019
Q2 | $106K | Sell |
1,750
-1,327
| -43% | -$71.5K | ﹤0.01% | 2999 |
|
|
2019
Q1 | $175K | Buy |
+3,077
| New | +$166K | ﹤0.01% | 2787 |
|
|
2018
Q4 | – | Sell |
-256
| Closed | -$10.8K | – | 4373 |
|
|
2018
Q3 | $10.8K | Hold |
256
| – | – | ﹤0.01% | 3695 |
|
|
2018
Q2 | $9.13K | Buy |
+256
| New | +$8.26K | ﹤0.01% | 3821 |
|
Other funds holding INSP
DM
VPM
VCM
BNP Paribas Financial Markets's INSP Position: Q1 2026 in Review
BNP Paribas Financial Markets reduced its Inspire Medical Systems (INSP) stake by 30% in Q1 2026, selling an estimated $9.45M and leaving 319,758 shares worth $16.5M. The position accounts for 0.01% of the portfolio, ranked #1287.
BNP Paribas Financial Markets first reported a position in INSP in Q2 2018 and has held it in 31 quarters since. The position peaked at $41.9M in Q4 2025. 301 funds tracked by Wall St. Rank hold INSP as of Q1 2026.
- BNP Paribas Financial Markets held 319,758 shares of Inspire Medical Systems worth $16.5M as of Q1 2026.
- BNP Paribas Financial Markets sold 135,052 Inspire Medical Systems shares in Q1 2026, an estimated $9.45M.
- Inspire Medical Systems made up 0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #1287 holding.
- BNP Paribas Financial Markets first reported a position in Inspire Medical Systems in Q2 2018 and has held it in 31 quarters since.
- BNP Paribas Financial Markets's Inspire Medical Systems position peaked at $41.9M in Q4 2025.
- 301 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.